Eagle Pharmaceuticals To Present Additional Data From Phase 3 Trial Showing Sustained Response of Amisulpride For Rescue Treatment of Postoperative Nausea and Vomiting At Upcoming ASPAN 2024 National Conference
Eagle Pharmaceuticals To Present Additional Data From Phase 3 Trial Showing Sustained Response of Amisulpride For Rescue Treatment of Postoperative Nausea and Vomiting At Upcoming ASPAN 2024 National Conference
Eagle Pharmicals將在即將舉行的ASPAN 2024全國會議上公佈來自3期試驗的更多數據，顯示阿米舒必利對術後噁心和嘔吐的搶救治療有持續的療效
Eagle Pharmaceuticals To Present Additional Data From Phase 3 Trial Showing Sustained Response of Amisulpride For Rescue Treatment of Postoperative Nausea and Vomiting At Upcoming ASPAN 2024 National Conference
Eagle Pharmicals將在即將舉行的ASPAN 2024全國會議上公佈來自3期試驗的更多數據，顯示阿米舒必利對術後噁心和嘔吐的搶救治療有持續的療效
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。